Onabotulinumtoxin A
- Generic Name
- Onabotulinumtoxin A
Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 20
- Registration Number
- NCT04984317
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
Onabotulinumtoxin A Versus Kenalog for Chronic Pelvic Pain
- First Posted Date
- 2015-02-23
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- Jamie Bartley, DO
- Target Recruit Count
- 21
- Registration Number
- NCT02369068
- Locations
- 🇺🇸
Beaumont Hospitals, Royal Oak, Michigan, United States
Intravesicular Onabotulinumtoxin A in Interstitial Cystitis
Phase 4
Completed
- Conditions
- Interstitial Cystitis
- Interventions
- Procedure: injections upper aspect of trigone of urinary bladderProcedure: injections on posterior bladder wall excluding the trigone
- First Posted Date
- 2014-11-21
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 27
- Registration Number
- NCT02297100
- Locations
- 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States
Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
Phase 3
Completed
- Conditions
- Raynaud's SyndromeScleroderma
- Interventions
- Drug: sterile saline solution
- First Posted Date
- 2014-06-17
- Last Posted Date
- 2016-12-22
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 40
- Registration Number
- NCT02165111
- Locations
- 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
Prevention of Bladder Dysfunction in Acute Spinal Cord Injury
Phase 4
Completed
- Conditions
- Spinal Cord InjuriesUrinary Bladder, Overactive
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2022-11-23
- Lead Sponsor
- Oslo University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT01698138
- Locations
- 🇳🇴
Oslo University Hospital, Oslo, Norway
🇳🇴Sunnaas Hospital, Nesoddtangen, Norway
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath